BioMarin Pharmaceutical (BMRN) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free BMRN Stock Alerts $82.44 -1.36 (-1.62%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNew Data for BioMarin's VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meetingprnewswire.com - May 4 at 4:00 PMCiti Just Cut Its Price Target on These 3 Stocksinvestorplace.com - May 3 at 2:31 PMVan ECK Associates Corp Has $12.93 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - May 2 at 6:41 AMBiotech Sector: M&A Fuels Renewed Excitementmsn.com - April 30 at 10:53 AMBioMarin Pharmaceutical Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Yearfinance.yahoo.com - April 30 at 10:53 AMAnalysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK)markets.businessinsider.com - April 30 at 5:52 AMBioMarin Pharmaceutical Investors Overfocused on Roctavian, Distracted From Enzyme Replacement Therapies, UBS Saysfinance.yahoo.com - April 29 at 6:57 PMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Expected to Post FY2025 Earnings of $3.03 Per Shareamericanbankingnews.com - April 29 at 5:24 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Short Interest Up 20.6% in Aprilmarketbeat.com - April 28 at 8:15 PMMotley Fool Wealth Management LLC Sells 18,667 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 28 at 11:51 AMBioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Cut to $112.00americanbankingnews.com - April 28 at 3:50 AMBioMarin Pharmaceutical (NASDAQ:BMRN) PT Lowered to $89.00americanbankingnews.com - April 28 at 2:42 AMBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by C WorldWide Group Holding A Smarketbeat.com - April 27 at 5:21 PMCantor Fitzgerald Reaffirms "Overweight" Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)americanbankingnews.com - April 27 at 5:18 AMBioMarin Pharmaceutical (NASDAQ:BMRN) PT Raised to $85.00americanbankingnews.com - April 27 at 5:18 AMBioMarin Pharmaceutical (NASDAQ:BMRN) PT Raised to $110.00 at Wells Fargo & Companyamericanbankingnews.com - April 27 at 5:18 AMCitigroup Cuts BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $91.00americanbankingnews.com - April 27 at 5:18 AMBeyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)finance.yahoo.com - April 27 at 3:36 AMBioMarin Pharmaceutical (NASDAQ:BMRN) PT Lowered to $112.00marketbeat.com - April 26 at 2:28 PMToday's Stocks Selling Off: Intel, Biomarin, Textronmsn.com - April 26 at 12:34 PMBuy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Earnings and Voxzogo’s Growth Potentialmarkets.businessinsider.com - April 26 at 7:34 AMBioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectationsfinance.yahoo.com - April 26 at 7:34 AMBioMarin Pharmaceutical Inc.: BioMarin Reports Record Financial Results for the First Quarter 2024finanznachrichten.de - April 25 at 9:33 PMScotiabank Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)markets.businessinsider.com - April 25 at 9:33 PMBioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Cut to $91.00marketbeat.com - April 25 at 7:48 PMBioMarin Pharmaceutical (NASDAQ:BMRN) Shares Gap Down to $91.20marketbeat.com - April 25 at 5:33 PMScotiabank Raises BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $85.00marketbeat.com - April 25 at 12:36 PMBioMarin Pharmaceutical's (BMRN) Overweight Rating Reaffirmed at Cantor Fitzgeraldmarketbeat.com - April 25 at 11:28 AMQ1 2024 Biomarin Pharmaceutical Inc Earnings Callfinance.yahoo.com - April 25 at 9:38 AMJennison Associates LLC Cuts Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 25 at 7:26 AM3 Biotech Stocks That Could Be Multibaggers in the Making: April Editioninvestorplace.com - April 25 at 6:00 AMBiomarin Pharmaceutical Inc (BMRN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth ...finance.yahoo.com - April 25 at 4:38 AMBioMarin Pharmaceutical Sees Unusually High Options Volume (NASDAQ:BMRN)americanbankingnews.com - April 25 at 1:06 AMUBS maintains Buy on BioMarin, sees Voxzogo potentialinvesting.com - April 24 at 11:37 PMBioMarin Reports Record Financial Results for the First Quarter 2024finance.yahoo.com - April 24 at 11:37 PMBMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Misses Revenue for Q1 2024msn.com - April 24 at 11:37 PMBioMarin Pharmaceutical Inc. 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - April 24 at 8:49 PMBioMarin Pharmaceutical (NASDAQ:BMRN) Updates FY 2024 Earnings Guidancemarketbeat.com - April 24 at 6:50 PMBiomarin Pharmaceutical Inc. Q1 Profit Increases, beats estimatesmarkets.businessinsider.com - April 24 at 6:37 PMBioMarin: Q1 Earnings Snapshotsfgate.com - April 24 at 6:37 PMBioMarin Pharmaceutical Inc. (BMRN) Q1 2024 Earnings: Surpasses Revenue and EPS Estimatesfinance.yahoo.com - April 24 at 6:37 PMBuy Rating Affirmed on BioMarin Amid Voxzogo Success and Promising Growth Outlookmarkets.businessinsider.com - April 24 at 1:34 PMAnalysts Offer Insights on Healthcare Companies: Biogen (BIIB) and BioMarin Pharmaceutical (BMRN)markets.businessinsider.com - April 24 at 1:34 PMTraders Buy Large Volume of Put Options on BioMarin Pharmaceutical (NASDAQ:BMRN)marketbeat.com - April 24 at 11:00 AMCalifornia Public Employees Retirement System Trims Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 24 at 8:26 AMabrdn plc Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 23 at 6:04 AMBioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Saysfinance.yahoo.com - April 22 at 7:30 PMZurcher Kantonalbank Zurich Cantonalbank Lowers Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 21 at 5:43 AMGuru Fundamental Report for BMRN - Benjamin Grahamnasdaq.com - April 19 at 7:26 PMAllspring Global Investments Holdings LLC Boosts Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)marketbeat.com - April 19 at 4:50 AM Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. BMRN Media Mentions By Week BMRN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼0.490.42▲Average Medical News Sentiment BMRN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼137▲BMRN Articles Average Week Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALNY News Today UTHR News Today IONS News Today MDGL News Today GMAB News Today TEVA News Today VTRS News Today BGNE News Today KRTX News Today RDY News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
